{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:14:41Z","timestamp":1793387681346,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7874","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1038\/s41586-021-03824-5","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T12:06:56Z","timestamp":1629288416000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["DAXX represents a new type of protein-folding enabler"],"prefix":"10.1038","volume":"597","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-0296","authenticated-orcid":false,"given":"Liangqian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-1859","authenticated-orcid":false,"given":"JiaBei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4373-4752","authenticated-orcid":false,"given":"Ronen","family":"Marmorstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-7725","authenticated-orcid":false,"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"3824_CR1","doi-asserted-by":"publisher","first-page":"aac4354","DOI":"10.1126\/science.aac4354","volume":"353","author":"D Balchin","year":"2016","unstructured":"Balchin, D., Hayer-Hartl, M. & Hartl, F. U. In vivo aspects of protein folding and quality control. Science 353, aac4354 (2016).","journal-title":"Science"},{"key":"3824_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1073\/pnas.012608599","volume":"99","author":"S Karlin","year":"2002","unstructured":"Karlin, S., Brocchieri, L., Bergman, A., Mrazek, J. & Gentles, A. J. Amino acid runs in eukaryotic proteomes and disease associations. Proc. Natl Acad. Sci. USA 99, 333\u2013338 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3824_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0092-8674(00)80294-9","volume":"89","author":"X Yang","year":"1997","unstructured":"Yang, X., Khosravi-Far, R., Chang, H. Y. & Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067\u20131076 (1997).","journal-title":"Cell"},{"key":"3824_CR4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1126\/science.281.5384.1860","volume":"281","author":"HY Chang","year":"1998","unstructured":"Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H. & Baltimore, D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281, 1860\u20131863 (1998).","journal-title":"Science"},{"key":"3824_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/35087019","volume":"3","author":"R Perlman","year":"2001","unstructured":"Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F. & Weinberg, R. A. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3, 708\u2013714 (2001).","journal-title":"Nat. Cell Biol."},{"key":"3824_CR6","doi-asserted-by":"publisher","first-page":"50566","DOI":"10.1074\/jbc.M406743200","volume":"279","author":"LY Zhao","year":"2004","unstructured":"Zhao, L. Y. et al. Negative regulation of p53 functions by Daxx and the involvement of MDM2. J. Biol. Chem. 279, 50566\u201350579 (2004).","journal-title":"J. Biol. Chem."},{"key":"3824_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ncb1442","volume":"8","author":"J Tang","year":"2006","unstructured":"Tang, J. et al. Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8, 855\u2013862 (2006).","journal-title":"Nat. Cell Biol."},{"key":"3824_CR8","doi-asserted-by":"publisher","first-page":"14075","DOI":"10.1073\/pnas.1008850107","volume":"107","author":"PW Lewis","year":"2010","unstructured":"Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C. & Allis, C. D. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl Acad. Sci. USA 107, 14075\u201314080 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3824_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nature07290","volume":"455","author":"MS Song","year":"2008","unstructured":"Song, M. S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813\u2013817 (2008).","journal-title":"Nature"},{"key":"3824_CR10","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1093\/nar\/gkz634","volume":"47","author":"I Mahmud","year":"2019","unstructured":"Mahmud, I. & Liao, D. DAXX in cancer: phenomena, processes, mechanisms and regulation. Nucleic Acids Res. 47, 7734\u20137752 (2019).","journal-title":"Nucleic Acids Res."},{"key":"3824_CR11","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1101\/gad.13.15.1918","volume":"13","author":"JS Michaelson","year":"1999","unstructured":"Michaelson, J. S., Bader, D., Kuo, F., Kozak, C. & Leder, P. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev. 13, 1918\u20131923 (1999).","journal-title":"Genes Dev."},{"key":"3824_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao, Y. et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199\u20131203 (2011).","journal-title":"Science"},{"key":"3824_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","volume":"34","author":"RK Gopal","year":"2018","unstructured":"Gopal, R. K. et al. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in hurthle cell carcinoma. Cancer Cell 34, 242\u2013255 (2018).","journal-title":"Cancer Cell"},{"key":"3824_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrm3810","volume":"15","author":"TP Knowles","year":"2014","unstructured":"Knowles, T. P., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 15, 384\u2013396 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3824_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","volume":"156","author":"ME Jackrel","year":"2014","unstructured":"Jackrel, M. E. et al. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156, 170\u2013182 (2014).","journal-title":"Cell"},{"key":"3824_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker, M. & Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45\u201351 (2013).","journal-title":"Nature"},{"key":"3824_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"3824_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrm3658","volume":"14","author":"H Saibil","year":"2013","unstructured":"Saibil, H. Chaperone machines for protein folding, unfolding and disaggregation. Nat. Rev. Mol. Cell Biol. 14, 630\u2013642 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3824_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)81223-4","volume":"94","author":"JR Glover","year":"1998","unstructured":"Glover, J. R. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73\u201382 (1998).","journal-title":"Cell"},{"key":"3824_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nchembio.455","volume":"6","author":"SK Sharma","year":"2010","unstructured":"Sharma, S. K., De los Rios, P., Christen, P., Lustig, A. & Goloubinoff, P. The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase. Nat. Chem. Biol. 6, 914\u2013920 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"3824_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nmeth.1697","volume":"8","author":"R Gupta","year":"2011","unstructured":"Gupta, R. et al. Firefly luciferase mutants as sensors of proteome stress. Nat. Methods 8, 879\u2013884 (2011).","journal-title":"Nat. Methods"},{"key":"3824_CR22","doi-asserted-by":"publisher","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro, T. F. et al. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS ONE 3, e1867 (2008).","journal-title":"PLoS ONE"},{"key":"3824_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/9353","volume":"6","author":"D Rentzeperis","year":"1999","unstructured":"Rentzeperis, D., Jonsson, T. & Sauer, R. T. Acceleration of the refolding of Arc repressor by nucleic acids and other polyanions. Nat. Struct. Biol. 6, 569\u2013573 (1999).","journal-title":"Nat. Struct. Biol."},{"key":"3824_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/271281a0","volume":"271","author":"JM Walker","year":"1978","unstructured":"Walker, J. M., Hastings, J. R. & Johns, E. W. A novel continuous sequence of 41 aspartic and glutamic residues in a non-histone chromosomal protein. Nature 271, 281\u2013282 (1978).","journal-title":"Nature"},{"key":"3824_CR25","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/S0021-9258(17)42162-4","volume":"269","author":"Y Adachi","year":"1994","unstructured":"Adachi, Y., Pavlakis, G. N. & Copeland, T. D. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J. Biol. Chem. 269, 2258\u20132262 (1994).","journal-title":"J. Biol. Chem."},{"key":"3824_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1515\/bchm3.1994.375.2.113","volume":"375","author":"M Vaesen","year":"1994","unstructured":"Vaesen, M. et al. Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol. Chem. Hoppe Seyler 375, 113\u2013126 (1994).","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"3824_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature19759","volume":"538","author":"D Wang","year":"2016","unstructured":"Wang, D. et al. Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature 538, 118\u2013122 (2016).","journal-title":"Nature"},{"key":"3824_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1110\/ps.062324206","volume":"15","author":"JS Butler","year":"2006","unstructured":"Butler, J. S. & Loh, S. N. Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature. Protein Sci. 15, 2457\u20132465 (2006).","journal-title":"Protein Sci."},{"key":"3824_CR29","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1021\/bi034218k","volume":"42","author":"D Ishimaru","year":"2003","unstructured":"Ishimaru, D. et al. Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42, 9022\u20139027 (2003).","journal-title":"Biochemistry"},{"key":"3824_CR30","doi-asserted-by":"publisher","first-page":"28152","DOI":"10.1074\/jbc.M112.340638","volume":"287","author":"AP Ano Bom","year":"2012","unstructured":"Ano Bom, A. P. et al. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J. Biol. Chem. 287, 28152\u201328162 (2012).","journal-title":"J. Biol. Chem."},{"key":"3824_CR31","first-page":"389","volume":"13","author":"R Zhang","year":"2010","unstructured":"Zhang, R. & Monsma, F. Fluorescence-based thermal shift assays. Curr. Opin. Drug Discov. Devel. 13, 389\u2013402 (2010).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"3824_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PA Muller","year":"2014","unstructured":"Muller, P. A. & Vousden, K. H. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25, 304\u2013317 (2014).","journal-title":"Cancer Cell"},{"key":"3824_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2014.04.030","volume":"55","author":"L Guo","year":"2014","unstructured":"Guo, L. et al. A cellular system that degrades misfolded proteins and protects against neurodegeneration. Mol. Cell 55, 15\u201330 (2014).","journal-title":"Mol. Cell"},{"key":"3824_CR34","doi-asserted-by":"publisher","first-page":"108418","DOI":"10.1016\/j.celrep.2020.108418","volume":"33","author":"G Zhu","year":"2020","unstructured":"Zhu, G. et al. TRIM11 prevents and reverses protein aggregation and rescues a mouse model of Parkinson\u2019s disease. Cell Rep. 33, 108418 (2020).","journal-title":"Cell Rep."},{"key":"3824_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc.2017.109","volume":"18","author":"VJN Bykov","year":"2018","unstructured":"Bykov, V. J. N., Eriksson, S. E., Bianchi, J. & Wiman, K. G. Targeting mutant p53 for efficient cancer therapy. Nat. Rev. Cancer 18, 89\u2013102 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"3824_CR36","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/onc.2010.462","volume":"30","author":"Y Chu","year":"2011","unstructured":"Chu, Y. & Yang, X. SUMO E3 ligase activity of TRIM proteins. Oncogene 30, 1108\u20131116 (2011).","journal-title":"Oncogene"},{"key":"3824_CR37","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.celrep.2017.03.010","volume":"18","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Enhanced degradation of misfolded proteins promotes tumorigenesis. Cell Rep. 18, 3143\u20133154 (2017).","journal-title":"Cell Rep."},{"key":"3824_CR38","doi-asserted-by":"publisher","first-page":"e1600014","DOI":"10.1126\/sciadv.1600014","volume":"2","author":"CF Yen","year":"2016","unstructured":"Yen, C. F., Harischandra, D. S., Kanthasamy, A. & Sivasankar, S. Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity. Sci. Adv. 2, e1600014 (2016).","journal-title":"Sci. Adv."},{"key":"3824_CR39","doi-asserted-by":"publisher","first-page":"31066","DOI":"10.1074\/jbc.M114.595124","volume":"289","author":"C M\u00e5nsson","year":"2014","unstructured":"M\u00e5nsson, C. et al. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (A\u03b242) aggregates leads to sub-stoichiometric inhibition of amyloid formation. J. Biol. Chem. 289, 31066\u201331076 (2014).","journal-title":"J. Biol. Chem."},{"key":"3824_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2020.10.002","volume":"33","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Upregulation of antioxidant capacity and nucleotide precursor availability suffices for oncogenic transformation. Cell Metab. 33, 94\u2013109 (2021).","journal-title":"Cell Metab."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03824-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:12:39Z","timestamp":1630480359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-021-03824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":40,"journal-issue":{"issue":"7874","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1038\/s41586-021-03824-5","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.Y. is a founder and equity holder of Evergreen Therapeutics LLC, which received investments from Wealth Strategy Holding Limited. J.S. is a consultant for Dewpoint Therapeutics, Maze Therapeutics, Vivid Sciences, Korro Bio, and ADRx. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}